Discussão de especialistas
O estado da OCT: para onde se dirige e principais considerações no contexto da retina
Especialistas clínicos e do setor debatem o estado atual da tecnologia de OCT e o seu futuro
15 maio 2020
· 65 MIN VISUALIZAÇÃO
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original.image_file.100.100.file/eric_w_schneider.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/271-oct-interpretation/image/eric_w_schneider.jpg/_jcr_content/renditions/original./eric_w_schneider.jpg"})
Autor
Eric W. Schneider, MD
Tennessee Retina
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.100.100.0,34,319,353.file/headshot-ar1.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/263-latest-in-oct-technology-fo-retinal-disease-management/image/headshot-ar1.jpg/_jcr_content/renditions/original.image_file.319.319.0,34,319,353.file/headshot-ar1.jpg"})
Autor
Angelo Rago
Carl Zeiss Meditec, Inc.
RESUMO
A evolução e o futuro da tecnologia de OCT, incluindo Swept-Source OCT e SD-OCT de elevado desempenho
Durante este webinar gravado, o especialista em retina, Eric Schneider, MD, Tennessee Retina e Angelo Rago, Diretor de Diagnóstico Oftalmológico, ZEISS, analisam a evolução da tecnologia de OCT desde que a ZEISS introduziu a tomografia de coerência ótica há quase quinze anos. Desde então, a tecnologia tornou-se o padrão de cuidados em todos os tipos de práticas, e também abriu novas possibilidades com a angiografia por OCT e a Swept-Source OCT. Segundo Rago, ao olharmos para o futuro nesta viagem, é importante que os médicos compreendam as tendências de adoção de tecnologia - especialmente a curva de adoção da OCT - ao considerarem tecnologias novas e emergentes.
O debate também explora:
- O papel da Swept-Source OCT
- OCT de alto desempenho: como pode mudar a sua prática clínica
- Coisas a ter em conta ao adquirir um equipamento de OCT hoje